Jacqueline L. Whatmore

Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide

Matthew Whiteman, Kim M. Gooding, Jacqueline L. Whatmore et al. · Diabetologia · 2010 · 233 citations · Full text

Life Sciences, Pharmacology, Physiology +6

Hydrogen sulfide and nitric oxide interactions in inflammation

Maria Letizia Lo Faro, Jacqueline L. Whatmore, Paul G. Winyard et al. · Nitric Oxide · 2014 · 201 citations

Life Sciences, Immunology, Physiology +14

The novel mitochondria-targeted hydrogen sulfide (H 2 S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro

Domokos Gerő, Roberta Torregrossa, Alexis Perry et al. · Pharmacological Research · 2016 · 179 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

The synthesis and functional evaluation of a mitochondria-targeted hydrogen sulfide donor, (10-oxo-10-(4-(3-thioxo-3H-1,2-dithiol-5-yl)phenoxy)decyl)triphenylphosphonium bromide (AP39)

Sophie Le Trionnaire, Alexis Perry, Bartosz Szczęsny et al. · MedChemComm · 2014 · 126 citations

Life Sciences, Biochemistry, Pharmacology +11

ADP-ribosylation Factor and Rho Proteins Mediate fMLP-dependent Activation of Phospholipase D in Human Neutrophils

Amanda Fensome, Jacqueline L. Whatmore, Clive P. Morgan et al. · Journal of Biological Chemistry · 1998 · 93 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14